| Date | Form | Description | Docs | XBRL | Pages |
| 05/27/21 | 8-K | Current report filing |
|
9 | |
| 05/04/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/09/21 | DEF 14A | Definitive proxy statements |
|
21 | |
| 04/02/21 | 8-K | Current report filing |
|
3 | |
| 03/30/21 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
22 | |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Read More...